Unique Ingredient Identifier 3VRD35U26C is listed as a ingredient substance
| RN | 53956-04-0 |
| EC | 258-887-7 |
| NCIT | C77525 |
| RXCUI | 1311505 |
| MF | C42H62O16.H3N |
| INCHI KEY | ILRKKHJEINIICQ-OOFFSTKBSA-N |
| SMILES | N.C[C@]12CC[C@@](C)(C[C@H]1C3=CC(=O)[C@@H]4[C@@]5(C)CC[C@H](O[C@H]6O[C@@H]([C@@H](O)[C@H](O)[C@H]6O[C@@H]7O[C@@H]([C@@H](O)[C@H](O)[C@H]7O)C(O)=O)C(O)=O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]3(C)CC2)C(O)=O |
UNII 3VRD35U26C AMMONIUM GLYCYRRHIZATE is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| ORAL | FILM, SOLUBLE | 0.3 MG |
| ORAL | GRANULE | 3.13 MG |
| ORAL | GRANULE, FOR ORAL SUSPENSION | 2.33 MG |
| ORAL | GRANULE, FOR SUSPENSION | 60 MG |
| ORAL | POWDER | 200 MG/1PKT |
| ORAL | POWDER | 200 MG/1SCP |
| ORAL | POWDER, FOR RECONSTITUTION | 270 MG/1BOT |
| ORAL | POWDER, FOR SOLUTION | 531.9 MG/1BOT |
| ORAL | SOLUTION | 125 MG/5ML |
| ORAL | SOLUTION, LIQUID | 1.5 MG/1ML |
| ORAL | SUSPENSION | 0.6 MG/5ML |
| ORAL | SYRUP | 1.25 MG/5ML |
| ORAL | TABLET | 4.67 MG |
| ORAL | TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE | 11.5 MG |
| ORAL | TABLET, ORALLY DISINTEGRATING | 1.4 MG |